| Akt | Protein kinase B |
| ALP | Alkaline phosphatase |
| APC | Adenomatous polyposis coli |
| AXIN | Axis inhibition protein |
| BA/TA | Bone area/total area |
| BFR | Bone formation rate |
| BMAD | Bone mineral apparent density |
| BMC | Bone mineral content |
| BMD | Bone mineral density |
| BMI | Body mass index |
| BMP-2 | Bone morphogenic protein-2 |
| BMPRI | BMP type I receptor |
| BMPRII | BMP type II receptor |
| BSP | Bone sialoprotein |
| BV/TV | Bone volume/total volume |
| CI | Confidence interval |
| CK1α | Casein kinase alpha |
| COL1 | Type I collagen |
| Conn.D | Connectivity density |
| Co-Smad | Common-mediator Smad |
| CTSK | Cathepsin K |
| Ct.Ar | Cortical area |
| Ct.Ar/Tt.Ar | Cortical area fraction |
| Ct.Th | Cortical thickness |
| CTX | Carboxyl-terminal cross-linked telopeptide of type 1 collagen |
| DKK1 | Dickkopf-related protein 1 |
| dLS | Double-labelled surface |
| Dlx5 | Distal-less homeobox 5 |
| DVL | Protein dishevelled |
| ES | Eroded surface |
| Foxo1 | Forkhead box protein O1 |
| GLUT4 | Glucose transporter 4 |
| GSK3β | Glycogen synthase kinase 3-beta |
| HOMA-IR | Homeostatic model assessment of insulin resistance |
| HOMA-β | Homeostatic model assessment of β-cell function |
| HR | Hazard ratio |
| IKK | Inhibitor of nuclear factor-kappa B |
| IRS | Insulin receptor substrate |
| IRβ | Insulin receptor β |
| I-Smads | Inhibitory Smads |
| KK-Ay | Yellow Kuo Kondo |
| LEF | Lymphoid enhancer-binding factor |
| LRP5 | Low-density lipoprotein receptor-related protein 5 |
| MAR | Mineral apposition rate |
| METS-IR | Metabolic score for insulin resistance |
| MS | Mineralising surface |
| NF-κB | Nuclear factor-kappa B |
| NHANES | National Health and Nutrition Examination Survey |
| Ob.N | Osteoblast number |
| Ob.S | Osteoblast surface |
| Oc.N | Osteoclast number |
| Oc.S | Osteoclast surface |
| OCN | Osteocalcin |
| OPG | Osteoprotegerin |
| OR | Odds ratio |
| OS | Osteoid surface |
| OSX | Osterix |
| OV | Osteoid volume |
| PIP2 | Phosphorylates phosphatidylinositol 4,5-bisphosphate |
| PIP3 | Phosphatidylinositol 3,4,5-trisphosphate |
| PI3K | Phosphatidylinositol 3-kinase |
| P1NP | N-terminal propeptide of type 1 collagen |
| p-Akt | Phosphorylated protein kinase B |
| p-β-catenin | Phosphorylated β-catenin |
| p-GSK3β | Phosphorylated glycogen synthase kinase 3-beta |
| QUICKI | Quantitative insulin sensitivity check index |
| RANK | Receptor activator of nuclear factor kappa B |
| RANKL | Receptor activator of nuclear factor kappa-B ligand |
| R-Smads | Receptor-regulated Smads |
| Runx2 | Runt-related transcription factor 2 |
| sFRP | Secreted Frizzled-related proteins |
| sLS | Single-labelled surface |
| Smad | Suppressor of mothers against decapentaplegic |
| SMI | Structure model index |
| Sost | Sclerostin |
| STZ | Streptozotocin |
| TAB2 | TAK1 binding protein 2 |
| TAB3 | TAK1 binding protein 3 |
| TAK1 | Transforming growth factor beta-activated kinase 1 |
| Tb.N | Trabecular number |
| Tb.Sp | Trabecular separation |
| Tb.Th | Trabecular thickness |
| TCF | T-cell-specific factor |
| TGF-β | Transforming growth factor-beta |
| TRAF6 | Tumour necrosis factor receptor-associated factor 6 |
| TRAP | Tartrate-resistant acid phosphatase |
| Tt.Ar | Total cross-sectional area inside the periosteal envelope |
| TyG | Triglyceride–glucose index |
| TyG-BMI | Tyg index with body mass index |
| TyG-WC | Tyg index with waist circumference |
| TyG-WHtR | Tyg index with waist-to-height ratio |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| ucOCN | Uncarboxylated osteocalcin |
| V-ATPase | V-type proton atpase |
| Wnt3a | Wnt ligand 3a |
| β-catenin | Beta-catenin |